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Evidence for the presence of tumor-specific antigens in human and animal tumors 
(1-7) and for the important role of specific cellular immunity in the process of tumor 
cell  elimination  (8-11)  continues to accumulate. This considerable body of informa- 
tion has,  however,  failed  to account for the often observed capacity of the host to 
reject homografts while  unable to overcome a tumor. The fact that tumors generally 
grow unchecked  and  metastasize  has  been variously ascribed  to  the  elaboration  of 
specific  antibody or other mechanisms capable of blocking cellular immune reactions 
(12-16); however, confidence in such explanations  is diminished by well-established 
situations in which prompt initial  tumor growth can no longer be overcome by the 
delayed immune response, or by the paradox of the "sneaking through" of a few tumor 
cells despite the obvious existence  of a  substantial specific immune response. 
There is now a large body of information showing that the host resistance to infec- 
tion can be modified and strikingly increased by nonspecific means  (17-20).  Recent 
investigations  have  indicated  that  resistance  to  tumors  may  involve  nonspecific 
factors as well as acquired specific immunity (21, 22). For example, the growth of both 
allogeneic and syngeneic tumors has been shown to be markedly inhibited in rats and 
mice  infected  with Nippostrongylus  brasiliensis  (23,  24),  Schistosoma  mansoni  (25), 
Toxoplasma or Besnoitia (26), or in animals injected with BCG (22, 24, 27-29), com- 
plete Freund's adjuvant (30),  Corynebacterium  parvum (22),  poly I/poly C 1 (24, 31), 
endotoxin (22, 24), peptone (24, 32), and still other affirmed stimulants of the reticulo- 
endothelial system. 
In showing  that  virus-induced  or carcinogen-induced syngeneic tumor cells 
may be effectively killed in vitro by activated normal rat peritoneal  cells,  the 
present work extends this body of evidence; these findings are consistent with 
the  thesis  that  the  nonspecific  mechanisms  heretofore  associated  with  resist- 
ance  to  infection  can  contribute  significantly  to  the  host's  defense  against 
tumors. 
* This work was supported by the Swiss National Science Foundation  (grant no. 3,516,71). 
1  Abbreviations used in this paper: DMBA,  dimethylbenzanthracene;  [3HITdR  ,  tritiated 
thymidine; MCA, methylcholanthrene; PMN, polymorphonuclear leukocytes; Poly I/Poly C, 
polyinosinic polycytidylic acid. 
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Materials and Methods 
A nimals.--Inbred DA rats were used throughout this study. They were kept on a standard 
diet and water ad libitum. 
induction  of Syngeneic Tumors.--Three different types of tumors were used: 
Polyoma tumors: Polyoma virus (wild type; kindly donated by Dr. R. Weil, Dept. de Bio- 
logie  Moldculaire,  Gen~ve)  was  suspended  to  contain  5  X  l0 s  plaque-forming  units/ml. 
Polyoma tumors were obtained after subcutaneous (s.c.) injection of 0.06 ml  of the virus sus- 
pension into  the neck  of 2-day old,  neonatally  thymectomized DA rats.  The  subcutaneous 
tumors were maintained in vivo either by serial s.c. implants or by s.c. injection of tumor cell 
suspensions into syngeneic recipients. As a source of target cells for in vitro tests, tissue culture 
lines were prepared from the transplanted polyoma tumors, grown in a  medium described by 
Schindler ctal.  (33)  and containing  10%  normal rat serum  (heat-inactivated for 60 rain at 
56°C), and maintained by in vitro serial passage. Cells were subcultured every 3rd day and 
106 cells were seeded per 250 ml Falcon culture flask (Falcon Plastics, Division of BioQuest, 
Oxnard, Calif.). 
Dimethylbenzanthracene tumors: Dimethylbenzanthracene  tumors  were  obtained  after  a 
single subcutaneous injection of 3.3 ml of 7.12  dimethylbenz(a)anthracene  ([DMBA]  Fluka 
AG, Buchs, Switzerland; dissolved in olive oil)  into inbred DA rats weighing 150-200 g. The 
tumors were maintained in vivo through serial passage by implanting pieces of tumor subcu- 
taneously into rats weighing 80-120 g. Tissue culture lines of DMBA tumors were developed 
as for polyoma tumors and grown in the same medium supplemented  with heat-inactivated 
20%  fetal calf serum  (Microbiological Associates, Inc.,  Bethesda,  Md.).  Cells were subcul- 
tured every 2-3rd day and 106 cells were seeded per 250 ml culture flask. 
Methyleholanthrene tumors: Methylcholanthrene  tumors  were  obtained  after  instillation 
into the stomach of 20 ml of methylcholanthrene ([MCA] Fluka AG) on each of 6 consecutive 
days into female DA rats  that had been splenectomized 1 or 2  days previously.  Mammary 
tumors were passaged in vivo as described for DMBA tumors. Tissue culture lines were de- 
veloped as described for p~lyoma tumors and grown in the same medium supplemented with 
10% normal, heat-inactivated rat serum. Cells were subcultured every 4th day and 106 cells 
were seeded per 250 ml culture flask. 
These tumor cell cultures were regularly tested for the presence of mycoplasma organisms 
after incubation for 2-4 days at 37°C on mycoplasma agar.  No mycoplasma contamination 
was ever detected in any of the cultures. 
Preparation  of Macrophage Monolayers.  Peritoneal cells were obtained  either from un- 
treated donor DA rats, or 3 days after intraperitoneal (i.p.) injection of 10 ml of 10% proteose 
peptone (Fluka AG [32])  by washing out the cavity with culture medium. Cultures were pre- 
pared by seeding approximately 2  X  106 macrophages into 35  X  10 mm Falcon plastic Petri 
dishes. After 15 min the medium was decanted and 2 ml of medium supplemented with 10% 
heat-inactivated normal rat or fetal bovine serum was added. After 2 h of incubation, the non- 
adhering cells were removed by intensive washing of the monolayers with jets of tissue culture 
fluid. After this procedure, lymphocytes constituted less than 3% and granulocytes less than 
0.2% of the culture. Tumor ceils (2  X  105 cells/dish) were immediately added to the mono- 
layer or after a  further 5 h  of culturing. 
Preparation  of Polymorphonuclear Leukocytes (PMN's).--Peritoneal cells were harvested 
from inbred DA rats 4 h after injection of 10 ml of 0.1% glycogen i.p. (Fluka AG [34]) and cul- 
tured for 2 h  in plastic Petri dishes as described before to remove macrophages. The nonad- 
hering cells consisting of at least 95% PMN's were used as a source of effector cells. 
Assessment of the l(ffects of interacting  Target CeUs with Ejector Cells.---Besides the assess- 
ment of the morphology (by phase-contrast microscopy or after fixation with methanol and 
staining with Giemsa) and of the viability (with 0.2% trypan blue) of effector and target cells, 
two more objective methods were used to follow the possible consequences of effector/target 
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Cytotoxicity  Tests.--Suspensions of tumor cells were first incubated for 30 rain at 37°C with 
~lCr  (sodium  chromate;  Eidgen.  Institut  ffir  Reaktorforschung,  Wtirenlingen,  Switzer- 
land; 50 #Ci 51Cr per 10 s ceils). Tumor cells were washed three times, then added to the macro- 
phage monolayers (2 X  105 tumor cells/35 mm Falcon plastic dish) and cultured at 37°C for 
15 h in a moist atmosphere containing 5% CO2 • Afterwards, the medium was decanted and the 
nonadhering cells  were removed by  intensive washing of the  dishes. After centrifugation, 
radioactivity was measured in sediments, supernatants, and the liquid obtained by solubiliza- 
tion of the adhering cells through the addition of 2 ml of 0.5 N  NaOH. Cultures containing 
labeled tumor cells alone were incubated and sampled simultaneously with the experimental 
cultures to determine the amount of label leaching spontaneously from the cells. Labeled tumor 
cells were killed by heating (60°C for 20 min) to determine the total  releasable label. Using 
these controls, cell death was expressed in the form: 
Experimental release  --  control release 
Total releasable label  -- control release X  100. 
Assessment  of Residual  Tumor Cell Proliferation.--Tumor  cells  (2  X  10 ~ cells/dish) were 
cultivated either alone or together with syngeneic peritoneal cells in 35 X  10 mm Falcon plastic 
tissue culture dishes for 2, 4, 6, 8, 10, 12, or 14 h a 37°C. Afterwards, the cells were exposed for 
60  rain at 37°C  to  1 #Ci  [3H]thymidine/dish ([3H]TdR;  methyl-3H;  5,000  mCi/mmol; The 
Radiochemical Centre, Amersham, Buckinghamshire, England and washed three times with 
cold medium. To ensure that the radioactive precursor was incorporated into DNA, nucleic 
acid radioactivity was measured in a liquid scintillation counter after it had been solubilized 
with hot perchloric acid (35). In some experiments, effector cells were first irradiated in vitro 
with 5,000 R and then immediately cultured together with target cells. 
FIG. 1.  Morphology of polyoma-induced rat tumor cells. Tumor cells were plated at 2 X 
10 '~ cells per 35 mm dish in medium supplemented  with 10% heat-inactivated normal rat serum 
and grown for 15 h. Living cells, phase-contrast microscopy. X  125. 628  TUMOR CELL ELIMINATION BY  MACROPHAGES 
To assess the effect of adherent peritoneal ceils on RNA synthesis by tumor cells, 2 X  10 a 
tumor cells cultivated for 14 h with peptone-induced macrophages were exposed for 60 min at 
37°C to 1 ~Ci [3H]uridine/dish ([5-~Hluridine;  20,000 mCi/mmol; The Radiochemical Centre), 
processed, and radioactivity measured as described for DNA incorporation. 
RESULTS 
Morphological Changes after the Interaction In Vitro oj Syngeneic Tumor Cells 
and Acrid,areal Peritoneal Macrophages.--Exploratory  experiments revealed that 
the procedure used in the Walker carcinosarcoma model system to assess effec- 
tor/target  cell  interactions,  i.e.  enumerating the  tumor  cells  that  could  be 
washed  off  from  the  cultures after  incubation, was  not  strictly quantitative 
since the syngeneic tumor cell lines also adhered firmly to  the culture  vessel. 
However, a marked difference was observed consistently when tumor cells were 
grown for 15 h; cultured in the absence of effector cells, the tumor cells covered 
part of the surface of the dish  and were well  spread  (Fig.  1).  In preparations 
where  tumor cells had  been cultured for  15  h  together with peptone-induced 
macrophages, tumor cell number was greatly decreased, the cells were shrunken, 
and most of these cells were covered by adhering macrophages. Despite the ob- 
vious decrease [n tumor cell number, no increase in cell debris was ever found in 
these preparations (Fig. 2). When normal, nonstimulated peritoneal cells were 
Flo. 2.  Morphology of polyoma-induced rat tumor cells grown under identical conditions 
as indicated in Fig.  1 but in the presence of 2 X  106 activated,  nonimmune rat peritoneal 
macrophages. Reduction in tumor cell number:  tumor cells were shrunken and covered by 
adhering macrophages. Living cells, phase-contrast microscopy. X 125. R.  KELLER  629 
cultured  with  tumor  cells  after  the nonadhering  cells had  been washed  off,  a 
less  marked  effect was seen:  tumor  cells  grown rather  densely showed partly 
normal  appearance  and  were  well  spread,  partly  shrunken,  and  were  often 
covered by a large number of adhering mononuclear cells (Fig. 3). A somewhat 
similar picture was seen when tumor cells were cultured with glycogen-induced 
PMN's (Figs. 4  and 5). 
The Nature of the Cytocidal Process.--Once  morphological  observations  had 
indicated that both activated macrophages and exudative PMN's could rapidly 
Fie,. 3.  Morphology of polyoma-induced rat tumor cells grown under identical conditions 
as indicated in Fig. 1 but in the presence of 2 X  l0 G  adherent,  normal peritoneal cells. Liver 
cells, phase-contrast  microscopy. X  125. 
and effectively eliminate syngeneic tumor cells in vitro, more objective means of 
assessing this process were investigated. 
Cytotoxicity.--When ~lCr-labeled polyoma- or carcinogen-induced tumor cells 
were cultured  alone, the amount of label leaching spontaneously from the cells 
was approximately 2 %/h.  Although up to 30%  of the label  was thus  released 
over  15  h,  the  cells  retained  viability  (>97%)  as  indicated  by dye exclusion 
tests (Table I). Culturing of ~lCr-labeled polyoma- or carcinogen-induced tumor 
cells with activated peritoneal macrophages at a ratio of approximately 1 : 10 for 
15 h  consistently yielded a  low but significant release of the label from target 
cells  (Table  I); and under these conditions the viability of effector and target 
cells,  as  assessed  by  trypan  blue  exclusion,  was  regularly  slightly  decreased. 630  TUMOR  CELL  ELIMINATION  BY  MACROPHAGES 
FI6.4.  Morphology of polyoma-induced rat tumor cells grown under identical conditions 
as indicated in Fig. 1 but in the presence of 2 k  106 glycogen-induced syngeneic polymorpho- 
nuclear leukocytes. Living cells, phase-contrast microscopy. X  125. 
FIG..5.  Morphology of polyoma-induced rat tumor cells grown under identical conditions 
as indicated in Fig.  1 but in the presence of 2 k  106 glycogen-induced syngeneic polymorpho- 
nuclear leukocytes. Note accumulation of effector cells on tumor cells. Living cells, phase-con- 
trast microscopy,  k  125. R.  KELLER  631 
In contrast, culturing exudative PMN's with the various target cell lines  pro- 
duced no cytotoxic effects; the release of SlCr and the ability to exclude the vital 
dye were within the same range as the controls (Table I). 
In following the time-course of macrophage cytotoxicity, the main increase in 
SlCr-release  was found to occur within the first 6 h of interaction with targets; 
afterwards levels  of 51Cr in  the  supernatants  remained more or less  constant 
(not shown). A similar time-course was evident when viability of target cells, 
as  assessed  by  trypan  blue  exclusion  tests,  was  taken  as  a  measure  of 
cytotoxicity. Provided that the effector to target cell ratio was within the same 
range  (10:1)  as  in  the preceding experiments,  adherent  peritoneal  cells  from 
normal, untreated DA rats, cultured for 6 h before the addition of tumor cells, 
displayed  a  degree of cytotoxicity similar  to peptone-induced, adherent peri- 
toneal cells. 
Proliferation of Tumor Cells.--The loss by tumor cells of the capacity to in- 
corporate DNA precursors, such as [3H]TdR,  was marked when they were ex- 
posed to nonimmune, activated macrophages or exudative PMN's (Table II). 
In contrast, tumor cell proliferation remained unaffected when tumor cells were 
cultured alone at a similar density (initial tumor cell number 2 X  10G). Control 
experiments confirmed that macrophages or PMN's alone did not incorporate 
TABLE  I 
Comparative  Cytotoxicity  for  Target Cells Exerted  by Activated  Macrophages  and  by Exudative 
PMN's 
Cells present in culture*  51Cr release from  Target cell death  Effector  cell death 
target cells  (trypan blue)  (trypan blue) 
%  %  % 
Tumor cells:~  0§  2.1  (-t-0.4)  -- 
Activated macrophages  --  --  7.5  (4-1.2) 
Activated macrophages +  tumor  13.2  (4-4.1)  12.5  (4-3.6)  14.6  (4-4.3) 
cells  (10:1) 
Exudative PMN's  --  --  4.6  (4-0.8) 
Exudative PMN's +  tumor cells  0  2.4  (4-0.6)  5.6  (4-1.1) 
(10:1) 
Each value represents the mean of 20 determinations. 
* Incubation was for 15 h. 
Polyoma-induced tumor cells were used in the present experiments. 
§ Spontaneous release from targets was taken as 0. 
TABLE  II 
Residual  Tumor Call Proliferation  after Culturing for 14 h with l~ffector Cells (Controls  =  100%) 
Cell mixture  Mean % of [ZHITdR incorporation at 14 h 
Macrophage/tumor cell  (10:1)  8.6  (4-4.4)* 
PMN/tumor cell  (10:1)  45.3  (4-6.2)* 
* Each value represents the mean of 30 determinations. 632  TUMOR  CELL  ELIMINATION  BY  MACROPHAGES 
measurable amounts of the radioactive precursor (36, 37). This system thus re- 
flects the residual proliferative capacity of target cells. Since the potential for 
growth  of  the  tumor  cells  was  markedly affected by  the  presence of  macro- 
phages or PMN's, this procedure was used to evaluate the elimination process. 
The capacity of tumor cells (2 X  10S/dish) to incorporate the RNA precursor 
[3H]uridine was  greatly decreased after interaction  for  14 h  with 2  X  106  ac- 
tivated  macrophages  (11  4-  4.7 %  of controls).  Since macrophages alone in- 
corporated a much smaller percentage (3  -4- 1.9 %) of the label incorporated by 
tumor celt controls, this decrease reflects the residual RNA  synthesis of tumor 
cells. 
Cytokinetics  of l]~e Cylostatic  Process.  The  time-course  of  the  elinfination 
process was followed using populations of activated peritoneal macrophages or 
glycogen-induced  PMN's.  Incorporation  of  ['~H]TdR  was  measured  after 
effector cells plus tumor cells or tumor cells alone had been cultured for periods 
of time ranging from 2  to  14 h.  Results such  as those shown in Fig. 6 demon- 
strate that in the presence of nonimmtme, activated macrophages, the ability of 
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FIG. 6.  Time-course  of ability to incorporate [3H]TdR by polyoma-induced  tumor ceils in 
the presence of activated, nonimmune maerophage  (effector to target cell ratio approximately 
10:1). Incorporation by target cells alone  =  100%. Each value represents the mean of 24 de- 
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polyoma-induced syngeneic tumor cells to incorporate [3H]TdR into  acid-pre- 
cipitable material is progressively lost as incubation proceeds.  In  this experi- 
ment where the ratio between macrophages (2 X  10  °) and tumor cells (2 X  10 5) 
was approximately 10:1, a marked decrease was detectable within 2 h, and by 14 
h proliferation of tumor cells had virtually ceased. Similar results were obtained 
when  macrophages  were  cultured  with  carcinogen-induced  tumor  cell  lines. 
Moreover, a  similar decrease in proliferative activity of the various syngeneic 
tumor cell lines was seen when tumor cells were allowed to grow for 4-8 h and 
peptone-induced, adherent peritoneal cells were then added to the cultures. 
Glycogen-induced peritoneal cells consisting mainly of PMN's cultured with 
target cells at a ratio of approximately 10:1, yielded a somewhat similar picture 
(Fig.  7).  However,  as compared with  macrophages,  PMN's were clearly less 
effective in any of the experimental conditions examined; moreover, decrease in 
target cell  proliferation occurred more slowly. Nonetheless the data show con- 
vincingly that in this system, PMN's as well as macrophages do have a distinct 
effect on target cell proliferation. 
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FIG.  7.  Time-course of ability to incorporate [3H]TdR by polyoma-induced tumor cells in 
the presence of exudative polymorphonuclear leukocytes (effector to target cell ratio approxi- 
mately 10:1). Incorporation by target cells alone =  100%.  Each value represents the mean of 
20 determinations. 634  TU~vIOR  CELL  ELIMINATION  BY  MACROPHAGI~;S 
The E feclor to Tumor Cell Ratio as Determinant of the Cyloslatic E ffecl.--The 
preceding experiments provide evidence that under  the in vitro conditions of 
this investigation a rather small proportion of macrophages or PMN's suffice to 
effectively diminish proliferation of tumor ceils. It was,  however,  essential to 
obtain further  information on the  extent  to which  the process depends on  the 
ratio of effector cells to target cells. Accordingly, incorporation of [~H]TdR by 
2  X  10  ~ tumor cells was measured  14 h  after culturing these cells with varying 
increments of activated macrophages or glycogen-induced PMN's. The results 
with po]yoma-induced tumor cells represented in Fig. 8  show  that the macro- 
phage killer effect is strikingly dependent on the effector cell to target cell ratio. 
When macrophages were in a  majority of 5- to 25-fold (not shown), a dramatic 
effect was observed consistently. Even when the effector to target cell ratio was 
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reduced to 1:1,  a  significant reduction in tumor cell proliferation was  still de- 
tectable, but a cell ratio of 0.1 : 1 often resulted in an increase in target cell pro- 
liferation.  Similar results  were  obtained  with  carcinogen-induced  tumor  cell 
lines. 
To ascertain whether the observed marked decrease in the growth potential 
of tumor cells achieved in the presence of macrophages was not merely a conse- 
quence of increased cell density in the culture,  104 tumor cells were interacted 
for  14 h  with  104  activated macrophages,  and  incorporation of [~H]TdR  then 
assessed. Under these conditions, the reduction in tumor cell proliferation was 
proportionately similar (50 =t= 6.8 %) to that obtained with 20-fold greater num- 
bers of both effector and target cells (ratio 1 : 1 ; Fig. 7). 
The dependence of residual proliferative ability of polyoma-induced tumor 
cells on  the actual ratio of PMN's present in the incubate is shown in Fig. 9. 
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Comparison of these results with those obtained using macrophages as effector 
cells reveal that the macrophages are far more effective in limiting tumor cell 
proliferation  than  are  PMN's,  and  that  less  than  1:1  effector to  target  cell 
ratios enhance rather than inhibit target cell proliferation. 
Results of further experiments assessing the influence of irradiated  (5,000 R) 
effector cells on target cell  proliferation showed that the elimination of target 
cells is not limited by X-irradiation  (Table liD. 
The Relative Significance of Cyloslalic vs. Cylotoxic Effects in the Elimination of 
Syngeneic  Tumor Cells.  Once  it  had  become evident  that  activated,  nonim- 
mune macrophages could modulate tumor cell proliferation by either cytotoxic 
or cytostatic effects (whereas exudative PMN's are producing only an inhibition 
of  tumor cell  proliferation),  it  was  important  further  to  distinguish  the  sig- 
TABLE III 
Effect of Untreated or Irradiated (5,000 R) l"~Jector Cells on Proliferation of Polyoma-Induced 
Tumor  Cells (Incorporation of  [3H]TdR; Percent of Control +SD) 
Pretreatment  of  Macrophage/target  cell ratio 
effector cells  10:1  5 : 1  1 : 1  0.1 : 1 
None  15.7  (4-6.1)  23.6  (-4-9.6)  65.1  (4-21.5)  126.1 (4-24.9) 
Irradiation  19.1  (4-7.1)  19.3 (=t=6.6)  74.0  (±11.4)  116.0  (4-13.7) 
PMN/target  cell ratio 
10:1  5:1  1:1  0,1:1 
None  41.0  (4-21.1)  66.9  (4-22.6)  121.0  (=t=23.5)  125.1 (4-27.3) 
Irradiation  31.5  (4-7.8)  51.0  (4-22.5)  61.5  (4-24.4)  86.7  (4-20.1) 
Each value represents the mean of 12 determinations. 
nificance of these two mechanisms. To this end, both macrophage-induced cyto- 
toxicity and inhibition of tumor cell proliferation were followed in cultures of 
activated macrophages plus targets in  the presence of silica  (100  200/~g/ml), 
an agent known  to be selectively toxic for macrophages (38,  39).  The results 
summarized in Table IV show  that in  the presence of silica,  tumor cells pro- 
liferate  essentially as  they would  in  the  absence of effector cells,  despite  the 
generation of a low but consistent degree of cytotoxicity. These data show clearly 
that cytotoxic effects do not contribute appreciably to the elimination process 
involved in the present in vitro model system. Thus, all available data are con- 
sistent with  the view that activated, nonimmune macrophages and exudative 
PMN's kill tumor cells primarily by affecting their proliferative ability. 
The  Relative  Significance  of  Call-to-Cell  Contact  vs.  Humoral  Esfects  in  the 
t'~limination  Process.--To  determine  whether  the  general  mechanism of anti- 
tumor cell action in the present in vitro system involved merely some change in 
the medium unfavorable for tumor cell growth, as opposed to direct ceil-to-cell 
contact,  the  effect of snpernatant  medium  from macrophage cultures and of 
macrophage lysates on tumor cell proliferation was investigated. The data repre- R.  KELLER  637 
sented in Table V  demonstrate  that  in presence of supernatants  or lysates  tu- 
mor  cell  proliferation  continued  unaffected.  Similar  experiments  were  per- 
formed to evaluate the possibility that the increased tumor cell growth observed 
at an effector to tumor cell ratio of 1 : 1 might reflect some favorable "condition- 
TABLE  IV 
Utilization  of Silica Destruction  of Macrophages to Discriminate  between Cytostatic and Cytotoxic 
Mechanisms for Tumor Cell Elimination 
Incubation mixture*  51Cr release  Tumor celt proliferation 
%  % 
Tumor cells:~  0§  100  (4-9.6) 
Tumor cells q- silica  0.5  (4-2.1)  92.6  (4-8.7) 
Activated macrophages q- tumor cells  7.0  (4-1.8)  14.7  (4-5.6) 
(I0:1) 
Activated macrophages +  tumor cells  4.8  (4-2.6)  83.5  (4-10.2) 
(10:1)  -4- silica 
Each value represents the mean of 12 determinations. 
* Incubation was for 15 h. 
:~ Polyoma-induced tumor cells were used for the present experiments. 
§ Spontaneous release from targets was taken as 0. 
TABLE  V 
Evidence for Lack of Significant  Cytostatic Action on  Tumor Cells by Macrophage  Supernatants 
and Lysates 
Tumor growth~ (incorporation  Quantity of macrophage supernatants or lysates* added to tumor cells  of [3H]TdR) 
Supernatants from 
Supernatants from 
Supernatants from 
Supernatants from 
(ratio 1 : 1) 
Supernatants from 
(ratio 5:1) 
Supernatants from 
(ratio 10:1) 
Supernatants from 
(ratio 1 : 10) 
Supernatants 
Lysates from 
Lysates from 
Lysates from 
Lysates from 
104 macrophages  112  (4-14.5) 
105 macrophages  101  (4-7.5) 
10 a macrophages  84  (4-11.6) 
cultures of macrophages -k  tumor cells§  115  (4-12.4) 
cultures of macrophages q-  tumor cells§  70  (4-18.5) 
cultures of macrophages q- tumor cells§  72  (4-19.6) 
cultures of macrophages -k  tumor cells§  63  (4-21.2) 
from 2 X  105 tumor cells  102  (4-6.8) 
104 macrophages  100  (4-9.7) 
105 macrophages  99  (4-11.5) 
106 macrophages  95  (4-9.3) 
107 macrophages  81  (4-17.4) 
Each value represents the mean of 12-16 determinations. 
* These were "activated" rat peritoneal macrophages taken 3  days after intraperitoneal 
injection of peptone. 
3) 2 X  105 polyoma-induced tumor cells cultured in 2 ml of "conditioned"  medium for 14 h 
at 37°C (2 X  105 tumor cells in fresh medium =  100%). 
§ 2 X  l05 polyoma-induced tumor cells were cultured with macrophages for 14 h at 37°C. 638  TUMOR  CELL  ELIMINATION BY  MACROPHAGES 
ing" of the medium. The results given in Table V  show  that tumor cell pro- 
liferation was not affected either by supernatants from macrophage cultures or 
from macrophage/tumor cell cultures. 
DISCUSSION 
Observations made many years ago and summarized by Gorer (40) drew at- 
tention to the fact that, besides the generally accepted killer properties of lymph- 
oid cells  in specific immune response against neoplasias, macrophage reactions 
are prominent in the rejection of tumor cells, especially during extensive vascu- 
larization. There has since accumulated much more evidence that macrophages 
from immunized hosts can eliminate tumor cells either by phagocytosis (41-43) 
or by killing them through cell contact (44--47). 
Recent work has shown that normal macrophages incubated with hyperim- 
mune spleen cells or supernatants of cultures of inmmne lymphocytes and the 
specific antigen are  toxic for specific target cells; moreover, contact with  the 
specific  antigen  also  renders  them  capable  of killing  antigenically  unrelated 
target cells (48). Under these conditions, the killing of tumor cells by macro- 
phages involves an immunologically specific interaction succeeded by a nonspe- 
cific lethal reaction. This mechanism is analogous to the well-known antimicro- 
bial  activity of macrophages in  animals  infected with living microorganisms 
(18). More recent studies have demonstrated that cross-protection among in- 
tracellular microorganisms extends beyond phylogenetic lines and is effective in 
the absence of the specific antigen  (19,  20). The present experiments confirm 
and extend some earlier findings (23, 24, 26, 31, 32, 49) indicating that inten- 
sive nonspecific stimulation as achieved by persistent infection or by nonspe- 
cific stimulants of the reticuloendothelial system enables phagocytic cell systems 
to kill tumor cells in a nonspecific manner. 
The present in vitro studies using various syngeneic rat tumor cell lines as 
targets confirm earlier morphological observations that normal activated macro- 
phages interfere in a  striking manner with allogeneic or syngeneic tumor tar- 
gets (24, 26, 32, 49; Figs. 1-3); moreover, the present work verifies this inter- 
action  by more objective means.  These  data  convincingly demonstrate that 
tumor cell proliferation, as assessed by their ability to incorporate [aH]TdR, is 
quickly and markedly inhibited in the presence of a rather modest majority of 
activated macrophages  (effector to target ceil ratio approximately 10:1)  and 
virtually ceases after 14 h  of contact  (Fig.  6).  Under  the same experimental 
conditions, RNA synthesis by tumor cells,  assessed by their ability to incorpo- 
rate  [aH]uridine,  was  found  to  be similarly depressed.  It is noteworthy that 
tumor cell proliferation is significantly inhibited even at a macrophage to tu- 
mor cell ratio of 1:1, but is often favored by a still lower proportion of macro- 
phages in the cultures (Fig. 8). Whether stinmlation of target cell proliferation 
by relatively few macrophages reflects artificial conditions of cell culture or is 
rather more representative of in vivo conditions needs further clarification. The R.  KELLER  639 
present data nonetheless show that compared with so-called killer lymphocytes, 
where ratios of several hundred lymphocytes per target cell are often required, 
the present system appears remarkably efficient in coping with tumor cells. 
It is generally agreed that growth of cells in culture depends greatly on the 
cell density. It therefore seemed important to evaluate whether the marked de- 
crease in  the growth potential  achieved by the presence of nonimmune,  acti- 
vated macrophages was a consequence either solely or in part of increased cell 
density in the culture.  The observations that  (a)  tumor cells cultivated with 
macrophages at a  ratio of 1:1  showed a  similar decrease in their proliferative 
capacity irrespective of whether the total cell number was 2  X  10  4 or 4  X  10  5 
and (b) that tumor cell proliferation remained unaffected when tumor cells were 
cultured  alone at a  similar density as with macrophages (2  X  lO  t cells/dish) 
are taken as indicating that the inhibition of tumor cell growth by effector ceils 
is real and not a  reflection of high  cell  density. Another important issue was 
whether in the present in vitro system the general mechanism involved in anti- 
tumor cell action was a reflection of the medium becoming unfavorable for tu- 
mor cell  growth or, the completely opposite alternative, a consequence of cell- 
to-cell contact. Various observations, such as (a) the strong parallelism in the 
appearance of cell aggregation and inhibition of tumor cell proliferation, (b) the 
failure of macrophages in presence of silica to affect tumor cell growth, and (c) 
the failure of macrophage culture supernatants or lysates to inhibit tumor cell 
growth,  all  point  towards  cell-to-cell  contact  phenomena  between  functional 
effectors and targets as the necessary precondition for attaining tumor cell dam- 
age. 
Signs of cytotoxicity for target cells,  such  as release of nCr and uptake of 
trypan blue, are already evident at an early stage of the interaction but are less 
pronounced than the inhibition of proliferative capacity (Table I). Up to now, 
cytotoxicity has been held largely responsible for tumor cell killing by macro- 
phages from immune and nonimmune hosts (26, 31, 48). Silica, an agent estab- 
lished as specifically toxic for macrophages (38, 39), was utilized to discriminate 
between cytotoxic and cytostatic mechanisms. In the presence of silica in the 
cultures,  tumor  cell  proliferation proceeds essentially as though macrophages 
were absent.  Cytotoxic activity, on  the other hand,  is generated  to a  degree 
similar to the silica-free controls, a finding that argues for a cytostatic mecha- 
nism having a predominant role in accounting for the macrophage effects seen 
in the present in vitro system (Table IV). 
The present work has shown that exudative PMN's can also kill targets, ap- 
parently by a mechanism similar to that of activated macrophages (Figs. 4, 5, 7, 
and 9). If such mechanisms are in fact operative in vivo, PMN's could also par- 
ticipate in the nonspecific elimination of tumor cells, especially under circum- 
stances where the migration time and the number of effector ceils available in a 
given region are limited. The conclusion that target cell damage by macrophages 
and PMN's is achieved by a similar mechanism is also supported by the failure 640  TUMOR  CELL  ELIMINATION BY  MACROPHAGES 
to detect cytotoxic effects by PMN's even at high effector to target cell ratios 
(50:1),  an  observation which differs from that made recently in another rat 
tumor (50). This discrepancy possibly involves the fact that in these studies, 
syngeneic ascites tumor cells were grown in vivo before being cultured in vitro 
together with PMN's and may thus have specific cell-bound antibody on their 
surface (50).  Our finding that heavy irradiation of effector cells does not di- 
minish their killer properties argues against an involvement of lymphoid cells 
in this process (51). On the other hand, it is entirely conceivable that lympho- 
kines play an important part in effector cell activation. 
Many important questions remain unanswered and some others newly arise 
from the present work. As this and earlier studies (52) indicate, "activation" of 
normal, nonimmune macrophages is  a  central and indispensable precondition 
for their achieving the capacity to eliminate tumor targets. Present knowledge 
does not permit the definition of which functional and biochemical activities are 
enhanced in the course of macrophage activation and which are decisive for the 
effector cell to recognize and to kill tumor targets. From the present demonstra- 
tion that in principle mononuclear phagocytes as well  as polymorphonuclear 
leukocytes are able to eliminate tumor cells it may be argued that the  killer 
mechanism  elicited by the  two  types of effector cells may be similar or even 
identical. All  experimental work thus far suggests that both types of effector 
cells achieve tumor cell killing only via close contact, but the actual mechanism 
involved remains obscure. 
Any meaningful analysis of the role of macrophage activation is greatly com- 
plicated by the now established finding that normal, unstimulated peritoneal 
cells cultured in vitro become progressively adherent through increasingcontact 
with the surface of the culture vessel; a few hours of such culture conditions can 
lead to activation that parallels that attained in  vivo. Such in vitro adherent 
cells achieve in  all  measurable  respects the capacity to eliminate tumor cells 
just  as  macrophages  taken  from  stinmlated  animals.  Since  adherence is  the 
characteristic feature of macrophages utilized for separating this cell from all 
other celt types, it becmnes difficult, indeed presently impractical, to differenti- 
ate between normal and activated macrophages. However, despite this bar to 
fully controlled experiments there are various findings suggesting that activa- 
tion of macrophages is indeed a necessary condition for eliminating tumor tar- 
gets (32, 52). Other basic issues such as the involvement of the tumor cell itself 
in the performance of macrophages, the recognition mechanism involved, and 
the specificity of the macrophage elimination process for tumor targets are the 
subject of continuing investigations  (Keller, R.,  and T. B/ichi, data in prepa- 
ration). 
The majority of experimental studies on tumor immunity, both natural and 
acquired,  have  understandably  focused  attention  on  specific  immune  phe- 
nomena, notably on thymic lymphocytes as the host cell responsive to the neo- 
antigens that characterize autochthonous tumors and their acquisition of killer R.  KELLER  641 
properties. However, as this and other studies (24, 26, 31, 32, 49, 50) show, non- 
immune  phagocytes by a  separate  mechanism  are  effective in killing  tumor 
cells. The study of these cells and their mode of action on tumor targets there- 
fore provide new opportunities for understanding the cellular basis of tumor re- 
sistance.  Indeed,  the  elimination of tumor cells by activated,  "nonimmune" 
phagocytes represents a form of host surveillance far more primitive and basic 
than that ascribed to T  lymphocytes. 
SUMMARY 
Syngeneic tumor cell lines induced in inbred DA rats by polyoma virus, di- 
methylbenzanthracene, or methy|cholanthrene were  interacted in  vitro with 
syngeneic effector cells.  Glycogen-induced peritoneal exudate cells,  predomi- 
nantly polymorphonuclear leukocytes, and proteose peptone-induced peritoneal 
cells, principally macrophages, were the effector cells employed. Activated, non- 
immune  macrophages  or  exudative polymorphonuclear leukocytes produced 
pronounced morphological changes in syngeneic tumor cells as evidenced by a 
substantial reduction in tumor cell numbers and appearance of shrunken cells, 
even though there was no increase in cell debris. Polymorphonuclear leukocytes 
exerted a  generally similar but quantitatively much diminished effect. These 
effector cells constantly produced a decrease in the incorporation by tumor cells 
of DNA precursors such as [~H]thymidine and of RNA precursors such as [~H]- 
uridine. In this regard, the effector cells were quite refractory to high doses of 
X-irradiation. 
Interaction of target cells with activated, nonimmune macrophages yielded 
low but consistent signs of cytotoxicity, whereas polymorphonuclear leukocytes 
gave no such effects. Elimination of functional macrophages by silica,  an agent 
specifically  toxic  for  macropbages,  resulted  in  unrestricted  tumor  cell  pro- 
liferation despite continued generation of cytotoxicity. Accordingly, cytostatic 
mechanisms appear to play a predominant role in the elimination of tumor cells 
by nonimmune phagocytes. Evidence from a variety of experimental approaches 
suggest that the cytostatic effect is dependent on cell-to-cell contact. 
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